Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). Issue 1 (13th January 2021)

• Record Type: Journal Article
• Authors: Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Okada, Yosuke; Araki, Eiichi; Yamazaki, Tsutomu; Kadowaki, Takashi
• Other Names: author non-byline.; Miyoshi Hideaki author non-byline.; Abiko Atsuko author non-byline.; Nagai Sou author non-byline.; Yanagisawa Katsuyuki author non-byline.; Kijima Hiromichi author non-byline.; Taneda Shinji author non-byline.; Saitoh Shigeyuki author non-byline.; Ikeda Daisuke author non-byline.; Hirano Fuminori author non-byline.; Miura Takanori author non-byline.; Miyamoto Yoshihiro author non-byline.; Yoshimura Haruhiko author non-byline.; Inoue Mitsutaka author non-byline.; Katoh Masahiko author non-byline.; Nakagaki Osamu author non-byline.; Yamamoto Chiho author non-byline.; Morikawa Akitsuki author non-byline.; Yoshida Kazuhiro author non-byline.; Furukawa Shin author non-byline.; Koshiya Takeshi author non-byline.; Sugawara Hajime author non-byline.; Uchida Takumi author non-byline.; Yamada Yuichiro author non-byline.; Katagiri Hideki author non-byline.; Yamaguchi Hiroshi author non-byline.; Takakubo Noe author non-byline.; Ishigaki Yasushi author non-byline.; Suzuki Susumu author non-byline.; Shimotomai Takashi author non-byline.; Tamasawa Naoki author non-byline.; Matsui Jun author non-byline.; Goto Takashi author non-byline.; Oizumi Toshihide author non-byline.; Susa Shinji author non-byline.; Daimon Makoto author non-byline.; Matsui Jun author non-byline.; Murakami Hiroshi author non-byline.; Sugawara Takashi author non-byline.; Akai Hiroaki author non-byline.; Matsumoto Masahiro author non-byline.; Nakamura Mari author non-byline.; Ogawa Yoshiji author non-byline.; Yokoshima Takao author non-byline.; Watanabe Tsuyoshi author non-byline.; Satoh Hiroaki author non-byline.; Shimabukuro Michio author non-byline.; Tsukamoto Kazuhisa author non-byline.; Kunimi Motoei author non-byline.; Satoh Jo author non-byline.; Okuyama Atushi author non-byline.; Ogawa Kazutaka author non-byline.; Eguchi Hideyuki author non-byline.; Kimura Mamoru author non-byline.; Kouno Hiroshi author non-byline.; Horikawa Yohei author non-byline.; Ikejima Shin author non-byline.; Saitoh Masaru author non-byline.; Minami Naoyoshi author non-byline.; Sekikawa Akihiro author non-byline.; Suzuki Ryo author non-byline.; Uchida Toyoyoshi author non-byline.; Nishimura Rimei author non-byline.; Hayashi Michio author non-byline.; Shimada Akira author non-byline.; Kawai Toshihide author non-byline.; Fujita Nobuya author non-byline.; Tomotsune Ken author non-byline.; Yamashita Shigeo author non-byline.; Naka Motoji author non-byline.; Hiyoshi Toru author non-byline.; Nagai Yoshiyuki author non-byline.; Katoh Tomotaka author non-byline.; Hamano Kumiko author non-byline.; Inukai Kouichi author non-byline.; Kondo Takuma author non-byline.; Tsumura Kazuhiro author non-byline.; Matsuzawa Yoko author non-byline.; Mimura Masahiro author non-byline.; Kawasumi Masahiko author non-byline.; Takei Izumi author non-byline.; Okubo Yoshiaki author non-byline.; Matsuda Masafumi author non-byline.; Tatsuno Ichiro author non-byline.; Banba Nobuyuki author non-byline.; Yamada Satoru author non-byline.; Ando Akihiko author non-byline.; Toyoda Masao author non-byline.; Suzuki Daisuke author non-byline.; Iijima Takahiro author non-byline.; Mori Yasumichi author non-byline.; Uehara Yutaka author non-byline.; Satoh Yoshihiko author non-byline.; Shimano Hitoshi author non-byline.; Isogawa Akihiro author non-byline.; Yahata Kazuaki author non-byline.; Asoh Yoshimasa author non-byline.; Kuwabara Koichiro author non-byline.; Takizawa Souichi author non-byline.; Tanaka Yasushi author non-byline.; Yokote Koutaroh author non-byline.; Tohgo Masako author non-byline.; Itoi Takanobu author non-byline.; Miyazaki Shigeru author non-byline.; Itoh Hiroshi author non-byline.; Shiba Teruo author non-byline.; Hirose Takahisa author non-byline.; Higa Mariko author non-byline.; Yamada Masanobu author non-byline.; Ogawa Osamu author non-byline.; Kuroki Masatoshi author non-byline.; Satoh Shinobu author non-byline.; Ujihara Makoto author non-byline.; Yamanaka Kenjiroh author non-byline.; Koyano Hajime author non-byline.; Yamakawa Tadashi author non-byline.; Atsumi Yoshihito author non-byline.; Takahashi Kenichiroh author non-byline.; Orime Kazuki author non-byline.; Hirano Tsutomu author non-byline.; Morimoto Jiroh author non-byline.; Awata Takuya author non-byline.; Itoh Takashi author non-byline.; Mizuno Yuzoh author non-byline.; Yamamoto Naoyuki author non-byline.; Miyatake Han author non-byline.; Yamaguchi Mina author non-byline.; Sone Hirohito author non-byline.; Yamane Kenji author non-byline.; Kure Masahiko author non-byline.; Kawabe Satoko author non-byline.; Kakei Masahumi author non-byline.; Yoshida Masashi author non-byline.; Itoh Hiroyuki author non-byline.; Minami Nobuaki author non-byline.; Kobayashi Kazuki author non-byline.; Fujino Yusuke author non-byline.; Shibuya Makoto author non-byline.; Fukui Kazuki author non-byline.; Hosokawa Midori author non-byline.; Nozaki Isao author non-byline.; Nawa Chigure author non-byline.; Ieiri Tamio author non-byline.; Watanabe Takayuki author non-byline.; Katoh Yoshio author non-byline.; Katabami Takuyuki author non-byline.; Handa Michiko author non-byline.; Shimada Issei author non-byline.; Ohya Kenichi author non-byline.; Ogawa Yoshihiro author non-byline.; Yoshimoto Takanobu author non-byline.; Nakamura Jiroh author non-byline.; Naruse Keiko author non-byline.; Sato Fumihiko author non-byline.; Sato Junko author non-byline.; Okayama Naotsuka author non-byline.; Imaeda Kenro author non-byline.; Yoshioka Syuko author non-byline.; Murakami Masako author non-byline.; Murase Takashi author non-byline.; Yamada Yoshihiko author non-byline.; Yano Yutaka author non-byline.; Sasaki Hiromitsu author non-byline.; Sumida Yasuhiro author non-byline.; Ogawa Kohei author non-byline.; Yonaha Osamu author non-byline.; Sobajima Hiroshi author non-byline.; Ito Mitsuyasu author non-byline.; Suzuki Atushi author non-byline.; Ishikawa Atsuko author non-byline.; Ichikawa Takehiko author non-byline.; Asano Shogo author non-byline.; Nakamura Makoto author non-byline.; Goto Shinobu author non-byline.; Hiroya Sakuma author non-byline.; Murase Hiroshi author non-byline.; Ogawa Shozo author non-byline.; Okamoto Hideki author non-byline.; Nagai Kotaro author non-byline.; Nagayama Koji author non-byline.; Yoshida Masanori author non-byline.; Takahashi Norio author non-byline.; Takami Kazuhisa author non-byline.; Ono Tsuneo author non-byline.; Morihiro Takanobu author non-byline.; Tanaka Daisuke author non-byline.; Shimomura Iichiro author non-byline.; Takahara Noriko author non-byline.; Miyata Satoshi author non-byline.; Tsugawa Mamiko author non-byline.; Yasuda Koichiro author non-byline.; Muro Seiji author non-byline.; Emoto Masanori author non-byline.; Koya Daisuke author non-byline.; Mineo Ikuo author non-byline.; Shiojima Ichiro author non-byline.; Kurose Takeshi author non-byline.; Akamizu Takashi author non-byline.; Ohashi Makoto author non-byline.; Kawabata Yumiko author non-byline.; Nishikawa Mitsushige author non-byline.; Nomura Emiko author non-byline.; Nishimura Yasuyuki author non-byline.; Ono Yasuhiro author non-byline.; Yamamoto Yasuhisa author non-byline.; Naka Keigo author non-byline.; Sakaguchi Kazuhiko author non-byline.; Yamamoto Taizo author non-byline.; Usuda Rika author non-byline.; Akahori Hiroshi author non-byline.; Kato Seika author non-byline.; Otsuka Akihito author non-byline.; Maegawa Hiroshi author non-byline.; Yamazaki Masahiro author non-byline.; Konya Hiroyuki author non-byline.; Umayahara Yutaka author non-byline.; Seta Takashi author non-byline.; Taki Hideki author non-byline.; Sekiya Masashi author non-byline.; Matsuoka Naoki author non-byline.; Mogami Shinichi author non-byline.; Fujii Sumie author non-byline.; Hibuse Toshiyuki author non-byline.; Tsuji Shingo author non-byline.; Sumi Hirofumi author non-byline.; Kumeda Yasuro author non-byline.; Kogure Akinori author non-byline.; Furukawa Kenji author non-byline.; Kuroe Akira author non-byline.; Sawaki Hideaki author non-byline.; Hibiki Narihiro author non-byline.; Kitagawa Yoshihiro author non-byline.; Bando Yukihiro author non-byline.; Ono Akira author non-byline.; Uenaka Rikako author non-byline.; Omoto Seitaro author non-byline.; Kita Yuki author non-byline.; Ri Eiko author non-byline.; Numaguchi Ryutaro author non-byline.; Kawashima Sachiko author non-byline.; Kisimoto Ichiro author non-byline.; Hosoda Kiminori author non-byline.; Araki Yoshihiko author non-byline.; Arimura Tetsuroh author non-byline.; Hashiramoto Mitsuru author non-byline.; Takeda Koumei author non-byline.; Matsutani Akira author non-byline.; Shikata Kenichi author non-byline.; Inoue Yasushi author non-byline.; Sawano Fumio author non-byline.; Kamei Nozomu author non-byline.; Ito Yasuo author non-byline.; Morita Miwa author non-byline.; Oda Yoshiaki author non-byline.; Kishimoto Rui author non-byline.; Hatao Katsuhiro author non-byline.; Hashiramoto Mitsuru author non-byline.; Mune Tomoatsu author non-byline.; Kawasaki Fumiko author non-byline.; Teragawa Hiroki author non-byline.; Yaga Ken author non-byline.; Ishii Keita author non-byline.; Hirata Kyouji author non-byline.; Nakatou Tatsuaki author non-byline.; Nitta Yutaka author non-byline.; Fujita Naoki author non-byline.; Yoneda Masayasu author non-byline.; Tsuru Masatoshi author non-byline.; Ando Shinichirou author non-byline.; Kakiba Toshiaki author non-byline.; Toyoshige Michihiro author non-byline.; Shiwa Tsuguka author non-byline.; Fujiwara Masazumi author non-byline.; Miyaoka Hiroaki author non-byline.; Imachi Hitomi author non-byline.; Shintani Yasumi author non-byline.; Sakai Takenori author non-byline.; Niiya Tetsuji author non-byline.; Fujimoto Shinpei author non-byline.; Minami Hisaka author non-byline.; Noma Yoshihiko author non-byline.; Tamaru Masaaki author non-byline.; Sayou Yoshitaka author non-byline.; Oyama Tomoyo author non-byline.; Torisu Masamoto author non-byline.; Fujinaka Yuichi author non-byline.; Kumon Yoshitaka author non-byline.; Miyauchi Shozo author non-byline.; Osawa Haruhiko author non-byline.; Onji Morikazu author non-byline.; Nakamura Toru author non-byline.; Hiasa Yoichi author non-byline.; Okada Yousuke author non-byline.; Yanase Toshihiko author non-byline.; Nishida Kenro author non-byline.; Nakamura Syuji author non-byline.; Doi Takashi author non-byline.; Kobayashi Kunihisa author non-byline.; Wada Nobuhiko author non-byline.; Higa Moritake author non-byline.; Matsushita Koji author non-byline.; Nishio Yoshihiko author non-byline.; Fujimoto Ryoji author non-byline.; Kihara Yasuyuki author non-byline.; Mine Shinichiro author non-byline.; Arao Tadashi author non-byline.; Tasaki Hiromi author non-byline.; Matsuo Yasuto author non-byline.; Matsuda Hirofumi author non-byline.; Uriu Kohei author non-byline.; Kobayashi Masakazu author non-byline.; Kanda Kazuko author non-byline.; Ibaraki Kazuo author non-byline.; Kaku Yoshio author non-byline.; Takaki Yasuhiro author non-byline.; Hazekawa Iwaho author non-byline.; Ebihara Kenji author non-byline.; Watanabe Eiichiro author non-byline.; Sakurada Iku author non-byline.; Muraishi Kazuhisa author non-byline.; Oshige Tamami author non-byline.; Yasuda Junichi author non-byline.; Iguchi Toyoshi author non-byline.; Sonoda Noriyuki author non-byline.; Adachi Masahiro author non-byline.; Ichino Isao author non-byline.; Horiuchi Yuko author non-byline.; Nakamura Udai author non-byline.; Uekihara Souichi author non-byline.; Morimitsu Shingo author non-byline.; Nakazawa Mitsuhiro author non-byline.; Seguchi Tadashi author non-byline.; Kaneko Kengo author non-byline.; Ono Yasuhiro author non-byline.;
• Is Part Of: BMJ open diabetes research and care. Volume 9:Issue 1(2021)
• Publication Date: 2021-01-13
• Subjects: diabetes mellitus -- type 2 -- dipeptidyl peptidase 4 -- safety -- registries; Diabetes -- Periodicals; 616.462005
• DOI: 10.1136/bmjdrc-2020-001787
• Languages: English
• ISSNs: 2052-4897

Abstract

Abstract : Introduction: Given an increasing use of dipeptidyl peptidase-4 (DPP-4) inhibitors to treat patients with type 2 diabetes mellitus in the real-world setting, we conducted a prospective observational study (Japan-based Clinical Research Network for Diabetes Registry: J-BRAND Registry) to elucidate the safety and efficacy profile of long-term usage of alogliptin. Research design and methods: We registered 5969 patients from April 2012 through September 2014, who started receiving alogliptin (group A) or other classes of oral hypoglycemic agents (OHAs; group B), and were followed for 3 years at 239 sites nationwide. Safety was the primary outcome. Symptomatic hypoglycemia, pancreatitis, skin disorders of non-extrinsic origin, severe infections, and cancer were collected as major adverse events (AEs). Efficacy assessment was the secondary outcome and included changes in hemoglobin A1c (HbA1c), fasting blood glucose, fasting insulin and urinary albumin. Results: Of the registered, 5150 (group A: 3395 and group B: 1755) and 5096 (3358 and 1738) were included for safety and efficacy analysis, respectively. Group A patients mostly (>90%) continued to use alogliptin. In group B, biguanides were the primary agents, while DPP-4 inhibitors were added in up to ~36% of patients. The overall incidence of AEs was similar between the two groups (42.7% vs 42.2%). Kaplan-Meier analysis revealed the incidence of cancer was significantly higher in group A than in group B (7.4% vs 4.8%, p=0.040), while no significant incidence difference was observed in the individual cancer. Multivariate Cox regression analysis revealed that the imbalanced patient distribution (more elderly patients in group A than in group B), but not alogliptin usage per se, contributed to cancer development. The incidence of other major AE categories was with no between-group difference. Between-group difference was not detected, either, in the incidence of microvascular and macrovascular complications. HbA1c and fasting glucose decreased significantly at the 0.5-year visit and nearly plateaued thereafter in both groups. Conclusions: Alogliptin as a representative of DPP-4 inhibitors was safe and durably efficacious when used alone or with other OHAs for patients with type 2 diabetes in the real world setting.